Please login to the form below

Not currently logged in


This page shows the latest behaviour news and features for those working in and with pharma, biotech and healthcare.

UK’s CMA fines drugmakers £260m for overcharging NHS for steroid med

UK’s CMA fines drugmakers £260m for overcharging NHS for steroid med

As well as imposing substantial fines, the CMA’s decision means the NHS will be able to seek damages for the firms’ behaviour, should it choose to do so,” said the

Latest news

  • Great expectations Great expectations

    And, of course, we quickly suffered from public health fatigue, which naturally impacted our behaviour. ... Now, most of the epidemiological community concurs that herd immunity is unlikely, which has impacted behaviour in terms of inoculation uptake.

  • Sense of belonging Sense of belonging

    For agencies, the clients they work with, their behaviour and how the organisation accepts or addresses less appropriate demands, are all factors that can affect how comfortable and connected team members

  • Pushing all the wrong buttons Pushing all the wrong buttons

    Secondly, we have learned that technology works best when it is considered in the context of both its environment and human behaviour.

  • WebMD acquires UK-based healthcare publisher MGP WebMD acquires UK-based healthcare publisher MGP

    Chesham, UK-based MGP produces content designed to help inform clinical decision-making and change clinical behaviour in line with best practice. ... MGP and Medscape have the trust and the engagement of hundreds of thousands of UK healthcare

  • Creating communication magic, without tricks Creating communication magic, without tricks

    Over the years mantras like ‘informed choice’ and ‘no decision about me without me’ have been coined to communicate the importance of ensuring the individual whose behaviours we are trying to ... There are many different behaviour change models,

More from news
Approximately 10 fully matching, plus 663 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 19 fully matching, plus 335 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 33 partially matching documents found.

Latest from PMHub

  • Climbing my own Lucid Ladder

    This creative partnership with a valued and collaborative pharmaceutical client continues to create pioneering solutions that change behaviour, improve clinical practice and advance health outcomes.

  • A Lucid Thirsty Thursday D&I Special

    behaviour change, metrics and data analytics. We partner with the pharma and biotech industry,  delivering life transforming value with connected capabilities to create pioneering solutions that change behaviour, improve clinical practice

  • Connecting capabilities in healthcare communications

    Instead, today's environment requires an integrated, multi-disciplinary approach to cut through the noise, change behaviour, build mental availability for a brand, and advance health outcomes.

  • Beyond yoga and smoothies – providing real support for employee well-being Beyond yoga and smoothies – providing real support for employee well-being

    salary to halve employee turnover and supercharge growth) but I have seen altruistic behaviour from leaders here that is genuinely selfless and commercially beneficial. ... Leaders that role model your values will instantly reduce stress and anxiety

  • Mednet Group’s growth spurt

    I am excited to be working with Mednet Group - I love that everyone here is so passionate about their work, how they are changing behaviour and improving patients’ lives!”.

More from PMHub
Approximately 50 fully matching, plus 358 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Securing a future for telehealth with immersive market research insights...